AR131282A1 - NOVEL COMPOUNDS - Google Patents
NOVEL COMPOUNDSInfo
- Publication number
- AR131282A1 AR131282A1 ARP230103313A ARP230103313A AR131282A1 AR 131282 A1 AR131282 A1 AR 131282A1 AR P230103313 A ARP230103313 A AR P230103313A AR P230103313 A ARP230103313 A AR P230103313A AR 131282 A1 AR131282 A1 AR 131282A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel compounds
- compounds
- novel
- methods
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², X y W son como se describen en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.The invention relates to novel compounds having the general formula (1) wherein R¹, R², X and W are as described herein, a composition including the compounds and methods of using the compounds.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22212126 | 2022-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR131282A1 true AR131282A1 (en) | 2025-03-05 |
Family
ID=84462879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230103313A AR131282A1 (en) | 2022-12-08 | 2023-12-06 | NOVEL COMPOUNDS |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4630420A1 (en) |
| JP (1) | JP2025540258A (en) |
| CN (1) | CN120303272A (en) |
| AR (1) | AR131282A1 (en) |
| TW (1) | TW202440569A (en) |
| WO (1) | WO2024121184A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| CN121358737A (en) * | 2023-06-03 | 2026-01-16 | 成都赜灵生物医药科技有限公司 | Pyridazines and uses thereof |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
| WO2025180453A1 (en) * | 2024-02-28 | 2025-09-04 | 纽欧申医药(上海)有限公司 | Pyridazine ring derivative and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020190793A1 (en) | 2019-03-15 | 2020-09-24 | Skyhawk Therapeutics, Inc. | Compositions and methods for correction of aberrant splicing |
| CN116867769A (en) * | 2021-02-08 | 2023-10-10 | 南京明德新药研发有限公司 | Substituted pyridazine phenol derivatives |
-
2023
- 2023-12-06 CN CN202380083769.1A patent/CN120303272A/en active Pending
- 2023-12-06 EP EP23818438.6A patent/EP4630420A1/en active Pending
- 2023-12-06 WO PCT/EP2023/084416 patent/WO2024121184A1/en not_active Ceased
- 2023-12-06 JP JP2025533089A patent/JP2025540258A/en active Pending
- 2023-12-06 AR ARP230103313A patent/AR131282A1/en unknown
- 2023-12-07 TW TW112147614A patent/TW202440569A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025540258A (en) | 2025-12-11 |
| EP4630420A1 (en) | 2025-10-15 |
| CN120303272A (en) | 2025-07-11 |
| TW202440569A (en) | 2024-10-16 |
| WO2024121184A1 (en) | 2024-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR131282A1 (en) | NOVEL COMPOUNDS | |
| CL2023003312A1 (en) | NLRP3 inhibitors | |
| AR131006A1 (en) | NOVEL COMPOUNDS | |
| CL2022001091A1 (en) | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors (application divisional 202001871). | |
| AR130984A1 (en) | NOVEL COMPOUNDS | |
| CL2021001330A1 (en) | New heterocyclic compounds | |
| CO2023014721A2 (en) | Heterocyclic compounds | |
| AR123424A1 (en) | NEW HETEROCYCLIC COMPOUNDS | |
| AR131278A1 (en) | NOVEL COMPOUNDS | |
| CO2023016212A2 (en) | Triazine derivatives and their use in cancer treatment | |
| CL2024004085A1 (en) | Macrocyclic Kras inhibitor compounds, used to treat cancer. | |
| AR132377A1 (en) | NOVEL COMPOUNDS | |
| CL2022000802A1 (en) | Heterocyclic arylmethylene compounds as kv1.3 potassium shaker channel blockers | |
| AR132456A1 (en) | NOVEL COMPOUNDS | |
| CO2022002000A2 (en) | New heterocyclic inhibitors of monoacylglycerol lipase (MAGL) | |
| CL2023002429A1 (en) | Novel pyrimidin-2-yl sulfonamide derivatives | |
| CL2022000019A1 (en) | New heterocyclic compounds | |
| CO2025003256A2 (en) | Novel deuterated derivatives of pyrimidin-2-yl sulfonamide | |
| ECSP23089582A (en) | SPIROINDOLINONE COMPOUNDS AS KV1.3 POTASSIUM AGITATOR CHANNEL BLOCKERS | |
| CR20240203A (en) | NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS | |
| CL2025000126A1 (en) | Indole sulfonamide derivative compounds and their use in treating myelin loss. | |
| CL2025000125A1 (en) | Indole sulfonamide derivative compounds and their use in treating myelin loss. | |
| AR133076A1 (en) | NOVEL COMPOUNDS | |
| AR133375A1 (en) | NOVEL COMPOUNDS | |
| AR131633A1 (en) | NOVEL PYRIMIDINYL SULFONAMIDE DERIVATIVES |